New drug karonudib tested in blood cancer patients
Disease control
Recruiting now
This early-phase trial tests the safety of a new drug called karonudib in up to 9 adults with blood cancers like leukemia who have no standard treatment options left. The study aims to find a safe dose and look for any signs that the drug works. It is too early to know if karonud…
Phase: PHASE1 • Sponsor: Thomas Helleday Foundation • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC